Aberdeen Group plc

Holdings History for Denali Therapeutics Inc. - COMMON STOCK (DNLI)

Symbol: DNLI on Nasdaq
Investment type: Equity / COMMON STOCK

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.05%	+0.02%	$33,564,285	2,032,967	+919,381	+83%	$16.51	Q4 2025
30 Sep 2025	0.03%	+0%	$16,169,269	1,113,586	+210,835	+23%	$14.52	Q3 2025
30 Jun 2025	0.02%	+0%	$12,629,486	902,751	+142,936	+19%	$13.99	Q2 2025
31 Mar 2025	0.02%	+0.01%	$10,329,685	759,815	+357,533		$13.60	Q1 2025
31 Dec 2024	0.02%	+0%	$8,198,507	402,282	+38,603	+11%	$20.38	Q4 2024
30 Sep 2024	0.02%	-0.01%	$10,593,969	363,679	-209,356	-37%	$29.13	Q3 2024
30 Jun 2024	0.03%	+0%	$13,305,873	573,035	+57,016	+11%	$23.22	Q2 2024
31 Mar 2024	0.02%	+0.01%	$10,588,710	516,019	+191,190	+59%	$20.52	Q1 2024
31 Dec 2023	0.02%	+0.02%	$6,970,830	324,829	+324,829	NEW	$21.46	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.